Hidden Markov models for the assessment of chromosomal alterations using
  high-throughput SNP arrays by Scharpf, Robert B. et al.
ar
X
iv
:0
80
7.
46
49
v1
  [
sta
t.A
P]
  2
9 J
ul 
20
08
The Annals of Applied Statistics
2008, Vol. 2, No. 2, 687–713
DOI: 10.1214/07-AOAS155
c© Institute of Mathematical Statistics, 2008
HIDDEN MARKOV MODELS FOR THE ASSESSMENT OF
CHROMOSOMAL ALTERATIONS USING HIGH-THROUGHPUT
SNP ARRAYS
By Robert B. Scharpf,1 Giovanni Parmigiani,2 Jonathan
Pevsner3 and Ingo Ruczinski4
Johns Hopkins Bloomberg School of Public Health, Sidney Kimmel
Comprehensive Cancer Center, Kennedy Krieger Institute and
Johns Hopkins Bloomberg School of Public Health
Chromosomal DNA is characterized by variation between individ-
uals at the level of entire chromosomes (e.g., aneuploidy in which the
chromosome copy number is altered), segmental changes (including
insertions, deletions, inversions, and translocations), and changes to
small genomic regions (including single nucleotide polymorphisms). A
variety of alterations that occur in chromosomal DNA, many of which
can be detected using high density single nucleotide polymorphism
(SNP) microarrays, are linked to normal variation as well as disease
and are therefore of particular interest. These include changes in copy
number (deletions and duplications) and genotype (e.g., the occur-
rence of regions of homozygosity). Hidden Markov models (HMM)
are particularly useful for detecting such alterations, modeling the
spatial dependence between neighboring SNPs. Here, we improve pre-
vious approaches that utilize HMM frameworks for inference in high
throughput SNP arrays by integrating copy number, genotype calls,
and the corresponding measures of uncertainty when available. Us-
ing simulated and experimental data, we, in particular, demonstrate
how confidence scores control smoothing in a probabilistic framework.
Software for fitting HMMs to SNP array data is available in the R
package VanillaICE.
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1. Introduction. Chromosomal DNA is characterized by variation be-
tween individuals at the level of entire chromosomes (e.g., aneuploidy in
which the chromosome copy number is altered), segmental changes (in-
cluding insertions, deletions, inversions, and translocations), and changes
to small genomic regions (including single nucleotide polymorphisms). A
variety of alterations that occur in chromosomal DNA, many of which can
be detected using high density single nucleotide polymorphism (SNP) mi-
croarrays, are linked to normal variation as well as disease and are there-
fore of particular interest [Shaw-Smith et al. (2004), Aguirre et al. (2004),
Aggarwal et al. (2005), Dutt and Beroukhim (2007), Sebat et al. (2007),
Szatmari et al. (2007)]. These include changes in copy number (deletions
and duplications) and genotype (e.g., the occurrence of regions of homozy-
gosity).
Copy number variations can arise through somatic and germline events.
While naturally occurring and often (but not always) benign, germline copy
number variations are more abundant than previously thought [Freeman et al.
(2006), Redon et al. (2006), Eichler et al. (2007)]. On the other hand, so-
matic copy number changes, such as gene amplifications and deletions, fre-
quently contribute to tumorigenesis (or might be the consequence of it).
Regions of homozygosity (i.e., long stretches of homozygous SNPs) can also
occur through somatic and germline events. A hemizygous deletion of one
chromosomal allele results in only one DNA copy, and therefore, SNPs in
that region will appear as homozygous (given current genotyping technolo-
gies that generate only biallelic calls). The definition of loss of heterozygosity
(LOH) refers to such a somatic event: for example, comparing a tumor and
normal sample from the same person, any heterozygous SNPs in the nor-
mal sample appear as homozygous SNPs in the tumor sample, in any region
where an allele was lost. As already noted, regions of homozygosity can also
occur through germline events. While chromosomal DNA is typically inher-
ited from both parents, under some circumstances an individual inherits two
copies of a chromosome from one parent. The inheritance of both homologues
of a pair of chromosomes from only one parent can be due to autozygosity
(homozygosity in which alleles are identical by descent) or to uniparental di-
somy [UPD, Robinson (2000), Engel (2006)]. Autozygosity and UPD do not
involve an aneuploidy (change in chromosomal copy number), and the re-
gion of homozygosity may extend over an entire chromosome or segmentally
across a subregion of a chromosome. The condition is termed uniparental
isodisomy (iUPD) if the two copies inherited from one parent are identical,
and results in stretches of homozygous SNPs. (If the two inherited copies
are different homologues, the result is uniparental heterodisomy, hUPD, but
does not result in stretches of homozygous SNPs.) In some cases, UPD is
thought to be benign, but can also be associated with disease [Prader–Willi
syndrome, Angelman syndrome, Beckwith–Wiedemann syndrome, see, e.g.,
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Altug-Teber et al. (2005)]. UPD can disrupt genomic imprinting, such that
imprinted genes (expressed preferentially from the paternal or maternal al-
leles) fail to be expressed. UPD can also cause homozygosity for autosomal
recessive traits such as cystic fibrosis [Zlotogora (2004)].
A variety of technologies have been applied for the assessment of chro-
mosomal abnormalities including conventional karyotyping (e.g., Giemsa
staining of metaphase chromosomes) and fluorescence in situ hybridiza-
tion (FISH). While the former only allows for the genome-wide detection
of major chromosomal amplifications and deletions, the latter allows for the
verification of suspected microdeletions as well as translocations and some
duplications. Array comparative genome hybridization (aCGH) permits a
genome-wide measurement of copy number variation using bacterial artifi-
cial chromosome (BAC) clones deposited on a microarray. This is a high
throughput technique, but the resolution is limited to tens or hundreds of
thousands of base pairs and no genotype data are obtained.
SNP microarray technology permits the genome-wide search for chro-
mosomal abnormalities, providing genotype and copy number estimates for
hundreds of thousands of SNPs in genomic DNA isolated from a biological
sample. Statistical tools for the analysis of such SNP chip data are typ-
ically employed to assess where the chromosomal changes have occurred,
and whether or not these changes are associated with disease. Regions of in-
terest are typically aneuploidies, that is, regions where copy number changes
(deletions and amplifications) have occurred, or regions with unusually long
stretches of homozygous genotypes (either naturally occurring, e.g., through
evolutionary pressure on a DNA segment, or through loss of heterozygosity,
LOH).
For the analysis of SNP chip data in general, three different tiers of es-
timation problems arise. (1) By SNP: how can we use the low-level data
(such as the fluorescence measurements in Affymetrix SNP chips) to op-
timally estimate the genotype and DNA copy number for each SNP in
the array? (2) By sample: how can we borrow strength between neigh-
boring SNPs, and infer regions of LOH and copy number changes in the
genome of the subject studied? (3) Between samples: how can we compare
the genotype of many subjects, infer common regions of abnormality, and,
for example, assess differences between affected subjects and normal con-
trols? This manuscript revolves around methods for tier 2, the assessment
of chromosomal abnormalities in one particular sample. However, informa-
tion derived from tier 1, in particular, uncertainty estimates of copy number
and genotype estimates, can be critically important and will be incorpo-
rated in the analysis. In particular, for the Affymetrix platform, originally
described as a high-throughput assay for calling genotypes at thousands
of SNPs [Kennedy et al. (2003)], there have been several algorithms pro-
posed for the appropriate adjustment and pre-processing of probe-level data,
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and the estimation of SNP-level summaries of probe-level data for geno-
type [DM, Di et al. (2005), RLMM, Rabbee and Speed (2006), BRLMM,
Affymetrix (2006), CRLMM, Carvalho, Speed and Irizarry (2007), SNiPer-
HD, Hua et al. (2007)] and copy number (CNAG, Nannya et al. (2005),
CARAT, Huang et al. (2006), PLASQ, Laframboise, Harrington and Weir
(2007), CN-RLMM, Wang et al. (2007)]. Notably, Laframboise, Harrington
and Weir (2007) and Wang et al. (2007) provide allele-specific estimates of
copy number.
We caution that, as with gene expression technologies, pre-processing of
probe-level data is an important consideration. For instance, several recent
papers have described fragment-length and sequence effects that may be
introduced by the polymerase chain reaction (PCR) used to amplify the
DNA [Nannya et al. (2005), Carvalho, Speed and Irizarry (2007)]. We as-
sume that SNP-level summaries for each interrogated SNP have been ad-
justed for probe-specific biases to the extent possible. Statistical models such
as CRLMM that use Hapmap data for training have been shown to provide
better genotype calls when the centers of the bivariate scatterplots for the
A and B allele intensities are less well defined [Carvalho, Speed and Irizarry
(2007)]. Genotype calls for most genotyping algorithms are concordant for
over 99.9% of the measured SNPs in the Affymetrix 100k and 500k chips
when performance is compared on apparently normal individuals represented
in the HapMap study.
Statistical methods that provide an indication of the uncertainty of the
genotype call [e.g., based on the single to noise ratio (SNR) and log likelihood
ratio (LLR) defined by CRLMM] can be particularly useful for statistical
algorithms devised to infer chromosomal abnormalities. Specifically, statis-
tical models that borrow strength from neighboring SNPs to infer loss or
retention of heterozygosity should incorporate the uncertainty of the geno-
type call estimate, giving less weight to genotype calls that are measured
with high uncertainty and more weight to well-estimated genotypes. To our
knowledge, this manuscript is the first one to address this issue. Figure 1
illustrates why the uncertainty in genotype calls can differ substantially. Sim-
ilarly, probe-specific biases for copy number estimates have been described
before, see, for example, Wang et al. (2007).
Before high-throughput SNP chips were widely available, array compara-
tive genomic hybridization (aCGH) was the most commonly used method to
assess DNA copy numbers, and assess regions in the genome where deletions
or amplifications occurred in a particular sample. Thus, many statisticians
have proposed approaches for aCGH based copy number estimation, and
some of these proposed methods are also relevant for SNP chip based copy
number analysis. Approaches for aCGH data include hidden Markov models
[Fridlyand et al. (2004), Guha, Li and Neuberg (2006)], segmentation algo-
rithms [Olshen et al. (2004), Picard et al. (2005), Venkatraman and Olshen
HMMS FOR THE ASSESSMENT OF CHROMOSOMAL ALTERATIONS 5
(2007)], wavelets [Hsu et al. (2005)], smoothing [Hupe et al. (2004), Eilers
and de Menezes (2005)] regression [Houseman, Coull and Betensky (2006),
Huang et al. (2005)], clustering [Wang et al. (2005)], and resampling
[Lai and Zhao (2005)]. The manuscript by Lai et al. (2005) and
Willenbrock and Fridlyand (2005) contain reviews and comparisons of the
performances of several of these proposed methods. In addition, many useful
extensions or alternative approaches for the above listed methods are being
proposed. Some recent publications have confirmed that naturally occurring
DNA copy number variations are more abundant than previously thought
[Freeman et al. (2006), Redon et al. (2006)], which can produce outliers in
the aCGH data. Integrating these known copy number variations as permis-
sible outliers into a hidden Markov model to assess where abnormal copy
number alterations have occurred has been proposed by Shah et al. (2006).
For the statistical analysis, SNP chip data differ from array CGH data in
two important ways: (a) SNP chips also provide information for the geno-
type, that is, give homozygous/heterozygous SNP calls, and (b) provide a
much denser coverage, currently generating genotype information and copy
number estimates at locations in excess of 500,000 SNPs. The correlation
structure between those estimates has to be an essential part of any statis-
tical modeling approach. The most promising methods currently available
Fig. 1. HapMap genotype calls (the gold standard) for a bad SNP (left) and a good SNP
(right) for 269 samples measured on Affymetrix 100k SNP chips. The HapMap consensus
genotype call (taken to be the gold standard) is indicated by color: AA (medium grey),
AB (white), and BB (dark grey). The separation between genotype clusters is SNP-spe-
cific. This figure motivates an approach that incorporates uncertainty estimates to control
smoothing.
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are based on hidden Markov models. In particular, to infer LOH regions
and to estimate copy numbers changes, the dChip software and methods are
among the most widely used in the scientific literature for the analysis of
SNP chip data. The dChip methods are based on separate hidden Markov
Models for genotype analysis [Lin et al. (2004), Beroukhim et al. (2006)] and
copy number [Zhao et al. (2004)]. The original dChipSNP HMM [Lin et al.
(2004)] was devised to assess loss of heterozygosity regions (a region with
an allelic loss, where heterozygote SNPs in a normal sample appear as ho-
mozygote SNPs in a tumor sample). This required paired tumor and normal
samples from the same subject. As these are often not available, an exten-
sion of this model was proposed by Beroukhim et al. (2006) to allow for
LOH assessment without paired samples (e.g., tumor only). Note that such
an approach using unpaired data would also be required in settings that
do not involve abnormal tissue, for example, when subjects with mental re-
tardation and apparently normal controls are investigated to assess possible
differences in the karyotypes. The dChipSNP hidden Markov Model for copy
number assessment [Zhao et al. (2004)] is somewhat similar in nature to the
one used for LOH analysis; see Zhao et al. (2004).
Copy number estimates and genotype calls, however, can provide com-
plementary information. For example, without copy number information,
genotype calls alone would not allow for a distinction of LOH due to dele-
tion or uniparental isodisomy (iUPD), which occurs when a subject inherits
the same copy of a chromosome (or parts thereof) twice from one parent.
While this has been recognized and concurrent analyses have been reported
[see, e.g., Zhou et al. (2004, 2005) and Ninomiya et al. (2006)], these analy-
ses were carried out separately for genotype calls and copy number estimates,
and the results visually compared. Not until very recently has the need for
an integrated analysis of copy number and genotype been addressed for the
first time. Colella et al. (2007) propose a Bayesian hidden Markov model
approach (QuantiSNP), using both genotype and copy number estimates
to infer underlying states (deletions, amplifications, copy neutral regions of
homozygosity, etc.) of interest. We caution though that data derived from
cancer samples might create substantial problems for HMM based methods
like QuantiSNP and our approach: DNA copy numbers larger than three
are quite possible in such settings, and thus, the number of possible states
expands dramatically. Further, noninteger copy numbers do make sense in
tumors due to the mix of normal and abnormal cells in the sample [i.e., mo-
saicism; see Ting et al. (2006) for an example]. In these settings, copy num-
ber based segmentation approaches might be more promising [Olshen et al.
(2004), Picard et al. (2005), Venkatraman and Olshen (2007)], in particular,
as the definition of a “genotype” is unclear. In this manuscript, we propose
a hidden Markov model for the integrated analysis of copy number and
genotype estimates, most applicable for abnormalities as a consequence of
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germline events. We also develop the methodology to integrate genotype and
copy number estimate uncertainty measures, and illustrate how integrating
such confidence scores of the SNP-level summaries in the HMM can improve
inference for the underlying hidden states using simulated and experimental
data. These ideas are implemented in the R package VanillaICE.
2. Methods. In this section we describe three HMMs, dependent on
whether genotype estimates (abbreviated ĜT), copy number estimates (ab-
breviated ĈN), or both ĜT and ĈN are available as defined by three classes
of objects for SNP array data [Scharpf et al. (2007)].
2.1. Genotype calls. Most algorithms that provide SNP-level summaries
of genotype assume a copy number of two, and report the genotype estimates
as such. We therefore assume throughout this paper that the ĜT are of the
generic form AA or BB and AB corresponding to ĤOM and ĤET, respectively.
The vanilla HMM with hidden states retention ($) and loss (!) of heterozy-
gosity require specification of the initial state probability distribution, the
emission probabilities (denoted by β below), and the transition probabilities
(denoted by τ below) between the true states. Commonly employed in the
literature for the transition probability is the “instability-selection” model
for LOH analysis [Newton et al. (1998), Beroukhim et al. (2006)] that de-
scribes the dependencies between the underlying states of adjacent SNPs as
a function of distance. For any two adjacent SNPs, θ is defined as the proba-
bility that the state of the first marker is not informative (denoted by Ic) for
the state of the second marker. As the distance between SNPs affects this
probability, it is modeled as θ(d) = 1− e−2d, where d is a genetic or physical
distance [e.g., 100 Mb units; see Beroukhim et al. (2006)] between adjacent
SNPs. We assume that with probability 1− θ(d), SNP(i) is informative (de-
noted by I) for SNP(i+1) and that no change in state occurs between the
adjacent SNPs. For example, this leads to
τ!/!(d) = P (!i+1|!i, d)
= P (!i+1, I|!i, d) + P (!i+1, I
c|!i, d)
= P (!i+1|I, !i, d)× P (I|!i, d)(2.1)
+ P (!i+1|I
c, !i, d)× P (I
c|!i, d)
= 1− θ(d) +P (!)× θ(d),
as the probability that the state of SNP(i+1) is !, given that the state of
SNP(i) with distance d was !. Also,
τ$/!(d) = P ($i+1|!i, d) = 1−P (!i+1|!i, d) = θ(d)×P ($).(2.2)
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P ($) and P (!) refer to the initial probabilities for $ and !, respectively.
These initial probabilities can be set as fixed constants using knowledge
from previous experiments, or alternatively, learned via the EM algorithm
[Dempster, Laird and Rubin (1977)].
Emission probabilities for states ! and $ are estimated as
β!(ĜT)∼ Binomial(p= 0.99) and β$(ĜT)∼Binomial(p= 0.7),(2.3)
where p is the probability of a homozygous genotype call. We use the above
probabilities as defaults to reflect values typically seen in experimental data.
In a region of retention $, about 70% of SNPs on average are homozygous,
while in a region of loss ! all SNPs are homozygous, but genotyping errors do
occur. Alternatively, as these probabilities are affected by the quality of the
assay, they can also be learned via the EM algorithm. In practice, we find
that our approaches are rather insensitive to changes in these parameters.
It is certainly also possible to use SNP-specific homozygosity rates here if
they are known from a reference population. Efficient computation of the
probability of the observed sequence given the model is carried out using the
forward algorithm as described in Rabiner (1989). The most probable state
sequence given the model is calculated via the Viterbi algorithm [Viterbi
(1967), Rabiner (1989)].
Integrating confidence estimates (ICE ). When confidence estimates are
available, the observed data at a SNP is the genotype call (ĜT) and the
uncertainty measure S
ĜT
. The joint distribution of ĜT and S
ĜT
depends on
the underlying state. For example, if the state for a particular SNP is !, the
emission probability is
β!{ĜT,SĜT}= f{ĜT | !} × f{SĜT | ĜT, !}.(2.4)
Note that the first of the two terms on the right-hand side of equation (2.4) is
simply the emission probability when estimates of uncertainty are not avail-
able. The second term can be understood as a weight for the former term that
depends on the confidence with which the call is made. The second term can
be approximated using a density estimate of the S
ĜT
where the gold stan-
dard is available. For example, using CRLMM on the 269 HapMap samples,
the distributions of the respective uncertainty measures for all four possible
combinations of called and true genotypes measured on the Affymetrix 100k
SNP chips are known. We use kernel based density estimates to obtain the
distributions of the confidence scores, given the true and called genotype
(separately for the Xba and Hind 50k chips):
f{ S
ĤOM
| ĤOM,HOM}, f{S
ĤOM
| ĤOM,HET},
(2.5)
f{S
ĤET
| ĤET,HOM}, f{S
ĤET
| ĤET,HET}.
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The first term in (2.5), for example, denotes the density of the scores when
the genotype is correctly called homozygous (ĤOM) and the true genotype
is homozygous (HOM). If the underlying state is !, then the true genotype
is always HOM and we assume that
f{S
ĤOM
| ĤOM, !}= f{S
ĤOM
| ĤOM,HOM} and
(2.6)
f{S
ĤET
| ĤET, !}= f{S
ĤET
| ĤET,HOM}.
If the underlying state is $, then the true genotype can be HET or HOM.
We therefore estimate the emission probabilities for state $ as
β${ĜT,SĜT}
= f{ĜT | $}f{S
ĜT
| ĜT,$}
= f{ĜT | $}(f{S
ĜT
,HOM | ĜT,$}+ f{S
ĜT
,HET | ĜT,$})
= f{ĜT | $}(f{S
ĜT
|HOM, ĜT,$}f{HOM | ĜT,$}(2.7)
+ f{S
ĜT
|HET, ĜT,$}f{HET | ĜT,$})
= f{ĜT | $}(f{S
ĜT
|HOM, ĜT}f{HOM | ĜT,$}
+ f{S
ĜT
|HET, ĜT}f{HET | ĜT,$}).
The unknown terms in equation (2.7), f{HOM | ĜT,$} and f{HET |
ĜT,$}, are also estimated from the HapMap samples.
2.2. Copy number. The hidden states for autosomal copy numbers are
hemizygous deletion (ց), two copies (→), and more than two copies (ր).
A typical, and from practical experience, quite reasonable assumption when
only copy number is considered (applied to aCGH and SNP chip data) is that
the logarithm of the copy number estimate, after normalization, is roughly
normally distributed around the true log copy number [see, e.g., Zhao et al.
(2004)], although slightly heavier tails may also be observed in practice.
More important however is the fact that the variability is not necessarily
constant across SNPs, which we will address in the ICE HMM. If the variance
was assumed to be constant (as done in the vanilla HMM), this parameter
can be learned via the EM algorithm [Dempster, Laird and Rubin (1977)],
or estimated in a robust manner, for example, using quantiles from the
observed data. In the examples presented here, we obtained a robust estimate
for the standard deviation of copy number estimates using the 16th and
84th percentiles of the log2 transformed ĈN (corresponding to plus minus
one standard deviation from the median). For a state S , the mean µS and
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variance σ2S of the Gaussians used to describe the emission probabilities
can be fixed at starting values, or updated by EM. In the vanilla HMM we
assume a constant σ2 and estimate the emission probabilities for state ց,
for instance (on the log2 scale, not divided by 2), as
βց(ĈN)≡ f(ĈN|ց)∼N(µS = 0,var = σ
2).(2.8)
The transition probability for the copy number HMM is the same as the one
described above.
Integrating confidence estimates (ICE ). The emission probabilities for the
HMM retains the same location parameters for the Gaussian, but with SNP-
specific standard errors for the ĈN. For a given SNP, the emission probability
for copy number two (→), for example, is
β→{ĈN|SĈN} ∼N(1, (σ× SĈN)
2).(2.9)
The scalar σ can be estimated from the sample at hand, or set equal to one
if S
ĈN
measures the actual variability of the copy number estimate around
the true copy number.
2.3. Copy number and genotype. For the joint analysis of copy number
and genotype, we extend the transition probabilities in equations (2.1) and
(2.2) to the hidden states normal (s), amplification (-), LOH (&), and dele-
tion ()). For the emission probabilities, we assume conditional independence
between the copy number estimates and the genotype calls:
f(ĈN, ĜT|S) = f(ĈN|S)× f(ĜT|S).(2.10)
This equation can be further simplified, as the copy number distribution
only depends on the true copy number, and the genotype distribution only
depends on the true underlying state being $ or !. For example, for the
deletion state we have
f{ĈN, ĜT | )}= f{ĈN | )} × f{ĜT | )}= f{ĈN |ց} × f{ĜT | !}.(2.11)
The terms in equation (2.11) can be estimated as described above for geno-
type and copy number. Emission probabilities for the other states can be
obtained similarly.
2.4. Simulation. The simulated data are available in the Bioconductor
package VanillaICE. The simulation comprises one subject’s genotype, copy
number, and confidences scores for 9165 SNPs on chromosome 1. A descrip-
tion of the 5 features simulated in chromosome 1, referred to by regions A–E,
and the underlying hidden states in these regions follows.
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Genotype calls. With the exception of Regions A, B and C in Figure 2,
we simulated 9165 genotypes (the approximate number of SNPs in the two
50k SNP chips) from a Bernoulli distribution with probability 0.7 of ĤOM.
Unless otherwise indicated, confidence scores for ĜT were obtained by ran-
dom draws of confidence scores in the Hapmap data when the CRLMM
ĜT agreed with the gold-standard as defined by consensus of the HapMap
genotyping centers. The reference distributions were made separately for
the Affymetrix 50k Xba and Hind chips, and hence, the confidence score
sampled for each SNP were made respective to the chip.
Copy number. The Affymetrix CNAT tool (version 3.0) was used to ob-
tain ĈN for the 9165 SNPs from a presumably normal individual in the
HapMap dataset (sample NA06993). Deletions and amplifications were sim-
ulated from Gaussian distributions with location parameters log2(1) and
log2(3), respectively. For the scale parameter, we used a robust estimate
of the log2 transformed copy number standard deviation, denoted by ǫ. To
illustrate how a confidence score such as a standard error of the copy num-
ber estimate could be useful, we simulated standard errors from a shifted
Gamma: Γ(1,2) + 0.3, where 1 is the shape parameter and 2 is the rate
parameter. To ascertain the effect of qualitatively high confidence scores on
the ICE HMM, we scaled ǫ by 12 . Similarly, to simulate less precise ĈN, we
scaled ǫ by 2.
Regions A–E were simulated as follows:
• Region A contains 200 SNPs spanning a physical distance of approxi-
mately 5 Mb. Two chromosomal segments of 99 homozygous genotypes
are separated by a chromosomal segment of 14 kb containing two het-
erozygous SNPs. Using a 2-state hidden Markov model and using only
the simulated genotypes as the observed data, the true underlying states
(number of SNPs) are ! (99), $ (2), and ! (99) for the 3 segments, re-
spectively. We augment the genotype calls with copy number estimates
obtained directly from the CNAT analysis of a normal Hapmap subject’s
chromosome 1. Using the 3-state HMM for copy number, the true under-
lying state is → (200). Modeled jointly, the true underlying state is &
(99), s (2) and & (99).
• Region B contains 100 SNPs spanning a physical distance of approxi-
mately 2 Mb. Two chromosomal segments each containing 49 SNPs are
both in regions of a hemizygous deletion. We assigned a homozygous geno-
type call to all 98 SNPs in the two hemizygous deletions. The two hemizy-
gous deletions are separated by a chromosomal segment of 360 basepairs
with copy number two. To simulate an incorrect genotype call (the true
genotype is homozygous for the 2 SNPs on the diploid segment), confi-
dence scores for the two heterozygous SNPs are drawn from the distri-
bution of confidence scores when the CRLMM genotype call of HET was
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Fig. 2. A simulated chromosome with 9165 SNPs. Top: The simulated ĜT with uniform
noise added to reduce overplotting (vertical axis) plotted against physical position (horizon-
tal axis). Bottom: A magnification of region A. Two SNPs in region A with high simulated
confidence scores are indicated by the square plotting symbol. Regions A–E are described in
more detail in Section 2.4. In truth, there are 4 different segments in state loss (!, indicated
in light grey above). The predicted hidden states from the vanilla (Van) and ICE HMMs
are denoted by color in the two bars beneath the data points. The ICE HMM detects each
of the 4 ! segments, whereas the vanilla HMM smoothes over a segment in A containing
two heterozygous SNPs at position 52.8 Mb. Utilizing confidence scores for the genotype
predictions, the ICE HMM may provide more precise locations for ! breakpoints.
incorrect. Copy number estimates and corresponding confidence scores
(standard errors) for the hemizygous deletion were simulated as described
above, with the exception that high confidence scores were assigned to
the two SNPs in the chromosomal segment with normal copy number.
The true underlying state for the genotypes in Region B is ! (100). The
true state for the copy number in region B is ց (49), → (2), and ց (49).
Modeled jointly, the true states are ) (49), s (2) and ) (49).
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• Region C is a segment containing 100 homozygous SNPs spanning < 2
Mb in a hemizygous deletion. The true underlying states are ! (100) in
the genotype HMM, s (100) in the copy number HMM, and ) (100) in the
joint HMM.
• Region D contains two segments with copy number 3 (< 1 Mb), separated
by a diploid segment containing 2 SNPs (9.8 kb). The two amplified frag-
ments are < 1 Mb. The true underlying states are $ (200) in the genotype
HMM; ր (99), → (2), and ր (99) in the copy number HMM; and - (99),
s (2) and - (99) in the joint HMM.
• Region E contains a microdeletion spanning 5 SNPs (94 kb) and a mi-
croamplification containing 3 SNPs (294 kb). We assigned high confidence
scores to the copy number estimates in both regions. The true underlying
states are ! (5) and $ (3) in the genotype HMM, ց (5) and ր (3) in the
copy number HMM and ) (5) and - (3) in the joint HMM.
3. Results. This section describes results obtained from fitting HMMs
to simulated and experimental data. The HMMs are written in the statis-
tical language R (http://www.r-project.org) using S4 classes and meth-
ods [Chambers (1998)]. In particular, the HMM is dependent on whether
genotype estimates (abbreviated ĜT), copy number estimates (abbreviated
ĈN), or both ĜT and ĈN are available as defined by three classes of ob-
jects for SNP array data [Scharpf et al. (2007)]. Organizing the statistical
methods in this way allows more flexibility to users interested only in char-
acterizing chromosomal abnormalities in genotype (loss of heterozygosity,
LOH) or copy number (deletion or amplification) respectively. When both
ĜT and ĈN are available, the HMM will distinguish between copy-neutral
LOH and deletion-induced LOH. We use the term LOH in this context as
an unusually long stretch of homozygous SNPs, though these regions can
be completely naturally occurring, for example, due to evolutionary pres-
sure on chromosomal segments. For the simulation, we simulate ĜT and
ĈN as described in Section 2.4, analyzing the ĜT and ĈN separately and
then jointly. For the experimental data, we use a HapMap sample with
a previously identified region of uniparental isodisomy, a mechanism for
copy neutral LOH. Both the simulation and experimental data are based
on 100k Affymetrix SNP chips (comprised of the Xba and Hind 50k chips).
All figures shown are also available in color as supplementary material at
http://biostat.jhsph.edu/˜iruczins/publications/sm/.
3.1. Simulated data. SNP-level summaries were obtained using a combi-
nation of real (experimental) and simulated data for 1965 SNPs measured on
chromosome 1 of the 50k Hind and Xba Affymetrix SNP chips, as described
in Section 2.4 for additional details. Because the states of the HMM are
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determined by whether genotype estimates (ĜT), copy number estimates
(ĈN), or both ĜT and ĈN are available, we organize the results accord-
ingly. For each example, we plot both the predictions of a HMM that uses
only the observed SNP-level summaries as input (vanilla), and a HMM that
integrates confidence estimates (ICE ) for the SNP-level summaries.
Genotype HMM. The hidden states for the genotype HMM are retention
($) and loss (!) of heterozygosity. In the upper panel of Figure 2 the simu-
lated ĜT are plotted with uniform noise added to reduce overplotting. The
predicted states from the vanilla and ICE HMMs are also shown. The pre-
dictions from the vanilla HMM are the same as the predictions of the ICE
HMM shown, with the exception of the region (A) magnified in the lower
panel of Figure 2, where the ICE HMM correctly identifies the $ segment.
Both approaches miss the 5 SNP spanning microdeletion in region E, but
otherwise correctly predict the true underlying states (see Section 2.4 for de-
tails). In general, for both the vanilla and ICE HMMs, the Viterbi algorithm
(conditional on other parameters of the HMM model) chooses an optimal
sequence of states that maximizes the likelihood of the observed genotype
calls. The predicted states reflect a trade-off between the likelihood of the
observed genotypes given the underlying states, and the transition probabil-
ities. Unlike the vanilla HMM, emission probabilities in the ICE HMM are
a function of the confidence scores (as described in Section 2), and factor
into the likelihood. Intuitively, a high confidence score at a particular SNP
has the effect of giving more weight to the emission probability and less
weight to the state of the neighboring SNPs when determining the optimal
sequence of states in the Viterbi algorithm. Hence, the sequence of states
that maximizes the likelihood of the observed genotype calls differ in the
ICE and vanilla HMMs when the confidence scores shifts the balance be-
tween the opposing forces of the emission and transition probabilities. In
particular, the high confidence scores at the two heterozygous SNPs in re-
gion A favor the emission probability for $, causing two breakpoints in this
region of ! and, hence, a more local smoothing of the HMM. Although the
emission probability for state $ is greater than for state ! at these two SNPs
in the vanilla HMM, the probability of having two breakpoints in a region
of ! for SNPs that are physically close is small as reflected in the transition
probability. Therefore, the vanilla HMM provides a smoothing that is less
localized, corresponding to a sequence of ! predictions in region A without
transitions to the normal state.
Copy number HMM. The hidden states for autosomal copy numbers are
hemizygous deletion (ց), normal (two) copies (→), and more than two
copies (ր). Figure 3 (upper panel) shows the ĈN of the simulated dataset.
In our simulation, chromosome 1 contains three amplifications ր (two seg-
ments in D separated by a segment with normal copy number, and one in
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Fig. 3. Top: Copy number estimates (vertical axis) versus physical position (horizontal
axis) for 9165 SNPs on a simulated chromosome. Bottom: A magnification of regions D,
B, and E. High confidence scores for the copy number estimates were simulated for the
square points in regions D, B, and E. The two bars beneath the data points in each figure
show the predicted hidden states from the vanilla (Van) and ICE HMMs. Note that where
the predictions differ in regions D, B, and E, the ICE correctly classified the hidden states.
Note that the vanilla HMM also indicates a (spurious) deletion to the left of region A, not
indicated by the ICE HMM due to high variability in those copy number estimates.
E), and four deletions ց (two segments in B separated by a segment with
normal copy number, and one segment each in regions C and E). Also shown
are the predicted states from the vanilla and ICE HMMs, respectively. The
predictions from the two HMMs differ in regions B, D, and E magnified
in the lower panel. Without confidence estimates for the copy number, the
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transition probabilities dominate the likelihood as specified by the emission
probabilities, and the vanilla HMM smoothes over the two SNPs with copy
number 2 in regions B and D, and the amplification in region E. The high
confidence scores used in this simulation for the copy number estimates in
these regions make the transition between states more favorable, and thus,
the ICE HMM makes the transition back to the normal state for regions
B and D, and detects the amplification in region E. Note that when the
confidences scores for the ĈN are low, as for the 2 SNPs with copy number
near two in the hemizygous deletion in region C, the predictions with ICE
and vanilla are identical. Also, the vanilla HMM detects a spurious deletion
to the left of region A. As the confidence scores for those copy number esti-
mates were low, the likelihood specified in the ICE HMM does not favor a
transition to a nonnormal state.
Genotype and copy number HMM. We plot both the ĜT and ĈN in the up-
per panel of Figure 4. By modeling ĜT and ĈN simultaneously, we expand
the state space of the HMM to include deletion-induced LOH ()), copy neu-
tral LOH (&), normal (s), and amplification (-). The predicted states from
the vanilla and ICE HMMs are also shown, and differences in predictions are
indicated in the lower panel. As before, ICE correctly classifies all SNPs into
the respective states, while the vanilla HMM, in the absence of uncertainty
estimates, smoothes over some loci (regions A, B, D), and fails to detect
the amplification (with high confidence scores) in region E. In contrast, the
vanilla HMM does detect the microdeletion in region E. The ability of the
vanilla HMM to detect the microdeletion in this example even in the ab-
sence of confidence scores is attributable to the additional information that
the genotype provides: SNPs in deleted regions all appear as homozygous,
in contrast to amplifications, where homozygous and heterozygous SNPs
occur. Additionally, the extra genotype information may reduce the occur-
rence of predicted deletions that are spurious. For instance, in the absence
of information on genotype calls in Figure 3, the vanilla HMM predicts a
small deletion to the left of region A. As heterozygous genotype estimates
in this region are incompatible with a deletion, the vanilla HMM no longer
predicts this region to be a deletion in Figure 4.
3.2. Experimental data. To illustrate the HMM approaches on experi-
mental data, we used a HapMap sample with a previously identified (but
not experimentally confirmed) UPD in chromosome 2. The Affymetrix tool
CNAT (version 3.0) and the R software CRLMM were used to obtain SNP-
level summaries of copy number and genotype respectively. We caution that
at this point in time the ĜT obtained using CRLMM (or the Affymetrix
tools) implicitly assume that the copy number is two—ideally, allele spe-
cific estimates should be used, and methods are under development (Rafael
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Fig. 4. Top: The ĈN in Figure 3 are superimposed on the ĜT in Figure 2. We fit
HMMs to the joint observation sequence of ĈN and ĜT without (vanilla) and with (ICE)
confidence scores of the SNP-level summaries. The predictions from these two HMMs are
represented by different shades of grey in the two bars beneath the data points in each panel.
We used square plotting symbols to indicate SNPs for which we assigned high confidence
scores to the genotype and copy number estimates.
Irizarry, personal communication). Also, software to obtain confidence scores
for ĈN based on probe-level variability and signal-to-noise ratio on the chip
[such as described in Wang et al. (2007)] is not yet available. However, differ-
ences in the SNP-specific standard deviations of the ĈN across a reference set
of 90 HapMap samples have previously been reported [see, e.g., Zhao et al.
(2004)], and can be used in a straightforward manner as measures of uncer-
tainty [specifically, using those deviations as the S
ĈN
in equation (2.9), and
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Fig. 5. Top: A confirmed UPD between 190 and 200 Mb is detected by both HMMs in a
HapMap sample from the CEPH dataset. Note that the vanilla HMM incorrectly predicts
a small deletion of 3 SNPs in the middle of this region, whereas the ICE HMM provides
a more global smoothing of the copy number estimates. Bottom left: a magnified view of
three possible LOH regions (not confirmed). Only the middle region (143 Mb) is identi-
fied by both HMMs as LOH. Because the CRLMM genotype calls agree with the HapMap
consensus, the chromosomal segment containing the two heterozygous SNPs at 140 Mb
is not a region of LOH, as predicted by the vanilla HMM. Bottom right: magnification of
the vanilla (top) and ICE (bottom) predictions for the feature at 150 Mb. Again, the true
genotype calls are heterozygous, and so the ICE HMM correctly identifies the chromosomal
segment containing the two heterozygous SNPs as normal.
estimating the scalar σ from the autosomal SNP copy number estimates in
the sample].
The upper panel in Figure 5 shows ĈN on the vertical axis against physical
position on chromosome 2. The region of predominantly called homozygous
SNPs at 190–200 Mb is a previously identified UPD [Ting et al. (2006)].
Also shown are the predictions from the vanilla and ICE HMMs. The con-
firmed UPD between 190 and 200 Mb is detected by both HMMs, though
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the vanilla HMM incorrectly predicts a small deletion of 3 SNPs in the
middle of this region, whereas the ICE HMM provides a more global (and
correct) smoothing of the copy number estimates. Also, the vanilla HMM
finds a spurious amplification at about 210 Mb. The lower panel on the left
provides a magnified view of the region between 135 and 155 Mb, where the
vanilla and ICE HMMs differ. Only the middle region (at about 143 Mb)
is identified by both HMMs as LOH (we again stress that we use the term
LOH here as copy neutral stretches of homozygous SNPs, naturally occur-
ring possibly due to evolutionary pressure on this chromosomal segment).
The chromosomal segment at about 140 Mb contains the two heterozygous
SNPs (confirmed in the HapMap data, and called as such by CRLMM), and
thus is not a region of LOH, as predicted by the vanilla HMM. The lower
panel on the right further zooms in on the vanilla and ICE predictions in the
region around 150 Mb. The two SNPs with heterozygous genotype calls at
about 151 Mb are truly heterozygous SNPs, and therefore, the ICE HMM
correctly identifies the chromosomal segment containing these two heterozy-
gous SNPs as normal. Due to the abundance of markers in the segment
around 151.25 Mb exclusively called homozygous, the ICE HMM still indi-
cates an LOH segment. Several studies have recognized the abundance of
short, copy-neutral, entirely homozygous regions [see, e.g., Beroukhim et al.
(2006)]. To illustrate the prevalence of short, homozygous sequences, we fit
the vanilla and ICE HMMs to the chromosome 2 data of the 30 CEPH trio
parents available from HapMap (60 independent samples), and highlight
these copy-neutral, all homozygous regions in Figure 6. Clearly visible is the
abundance of these regions, and the enriched locations along chromosome 2
(possibly explained by evolutionary pressure).
3.3. A vanilla/ICE comparison. We performed additional simulations
to contrast the performances of the vanilla and ICE HMMs. Since large
deletions and amplifications can easily be picked up by both approaches, we
focused on small deletions and amplifications, spanning between 2 and 10
consecutive SNPs. Since the results were as expected, we only describe the
effects of the copy number variability and confidence scores on the detection
of small deletions in detail.
The experimental data consisted of genotype calls and copy number as
described in Section 2.4. Copy number confidence scores were obtained by
weighting the robust estimate of the within-chip log2 copy number standard
deviation by the standardized SNP specific standard deviation derived from
a reference set of 90 HapMap samples (e.g., this weight for one particular
SNP was the ratio of the across sample standard deviation for the SNP and
the median of all those numbers across all SNPs). Simulated in these data
were 450 sets of copy number estimates and confidence scores for deletions
ranging from two to ten consecutive SNPs (50 data sets for each deletion
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Fig. 6. An image of the predictions from the vanilla HMM fit to chromosome 2 of the
60 parental samples in the CEPH trios dataset (top). The x-and y-coordinates used for
the image are physical position and subject, respectively. Subject NA07056 has a confirmed
UPD at 195 Mb. Also plotted are the frequencies of LOH across the 60 samples (middle)
and the cytoband (bottom).
size). The locations of the deletions were randomly selected on chromosome
1 for each data set. The copy numbers in the deletions were simulated from a
log-normal distribution with mean zero (indicating a true DNA copy number
equal to one), and a standard deviation equal to a scaled version of the
SNP specific variability described above. The scalar K controlled whether
more (K < 1) or less (K > 1) precise copy number data than average were
encountered in the deletion. For both vanilla and ICE, we calculated for
each simulated data set the difference in log likelihoods between making a
transition to the state for deletion ()) from the normal state (s) for the range
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Fig. 7. Differences between the log likelihoods for the correct and incorrect state sequences
for the vanilla (light grey) and ICE (dark grey) HMMs are indicated in the upper panels.
The differences are shown for deletions of different sizes (horizontal axis), and four differ-
ent scale parameters K for the copy number estimate variability in the simulated deletions
(0.4, 0.7, 1.0, 1.3, left to right). The data were scaled to fit the panels, and slightly smoothed
from the raw data by exploiting an obvious mean and variance relationship. The middle
row of panels shows the estimated probabilities of the differences in log likelihoods being
positive (e.g., the proportion of instances when the correct model was favored over the in-
correct one), assuming normality of the differences in the log likelihoods. The lower row
of panels shows the estimated differences in these probabilities between ICE and vanilla.
of the simulated deletion (and back after the deletion), versus staying in the
normal state throughout. In other words, we calculated the difference of the
log likelihood of the true state sequence minus the log likelihood of assigning
the normal state s to all SNPs.
The upper row of panels in Figure 7 indicate the distributions of the
differences in the log likelihoods for both the vanilla (light grey) and ICE
(dark grey) HMMs, shown for the deletions of different sizes, and using four
different scale parameters K. For the first two panels, the variability in the
simulated copy number estimates in the deleted region was less than in the
original data (the standard deviations were reduced to 40% and 70% of the
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original, respectively), and for the fourth panel the standard deviation in
the simulated copy number estimates in the deleted region was increased by
30%. The middle row of panels shows the respective estimated probabilities
of the differences in log likelihoods being positive, for example, the propor-
tion of instances when the correct model was favored over the incorrect one.
The lower row of panels shows the difference in these probabilities between
ICE and vanilla. Quite obvious is the fact that the ability to detect micro-
deletions of a few SNPs depends on precise data, and the knowledge of that
precision. For example, when the standard deviation of the simulated copy
number estimates in the deletion was reduced to 40%, ICE was able to con-
sistently detect even the smallest deletions, while vanilla was only able to do
so for deletions of size 5 or larger (left panels). Naturally, larger deletions are
easier to detect for both methods. As the quality of the data decreases (sim-
ulated here as an increase in the variability of the copy number estimates in
the deletion), the ability of ICE to detect the deletion suffers substantially,
while vanilla is almost agnostic to these changes. When the standard devi-
ation of the simulated copy number estimates in the deletion was increased
by 30%, vanilla picked up the deletion more often than ICE (right panels).
The reason for this is as follows: since the variability in the copy number es-
timates is increased, the evidence of a deletion being present decreases, and
ICE acknowledges this fact by incorporating the confidence estimates. Thus,
the decrease in the proportion of instances where ICE favors a deletion over
the normal state is a feature of the algorithm. The price to pay, otherwise,
is in the number of false positives (i.e., the number of incorrectly inferred
deletions at other loci). Simulating 200 “synthetic” normal chromosome 1q
arms with K = 1.3 across all SNPs, vanilla indicated spurious small dele-
tions in 50 of these artificial chromosomal arms (for a total of 86 incorrect
state predictions), while ICE indicated none.
4. Discussion. Chromosomal DNA varies between individuals at the level
of entire chromosomes, chromosomal segments, and changes in small ge-
nomic regions down to one nucleotide (including single nucleotide polymor-
phisms, SNPs). Many of these variations appear to be completely benign,
but some are known or suspected to be associated with disease. Associa-
tion studies often use some SNPs (in candidate gene studies) or hundreds of
thousands of SNPs (in genome wide association studies) as potential candi-
dates or markers of genes to investigate the relationship between genotype
and phenotype. However, the abundance of copy number variations in the
human genome and their role in disease have played an increasingly promi-
nent role. In particular, the “common disease, common variant” paradigm
has been challenged for some diseases [McClellan, Susser and King (2007);
see, e.g., Sebat et al. (2007) for a case study on autistic and apparently
normal subjects]. Undoubtedly, this change is due in part to the recent
HMMS FOR THE ASSESSMENT OF CHROMOSOMAL ALTERATIONS 23
technological advancement, in particular, on high density single nucleotide
polymorphism (SNP) microarrays which allow for the detection of these al-
terations. Besides copy number variations such as deletions and duplications,
copy-neutral stretches of homozygosity can also be of scientific interest, as
uniparental disomy as one such example has been implicated in disease.
Copy number variations and loss of heterozygosity can arise through so-
matic and germline events. In this manuscript, we developed methods most
applicable for abnormalities as a consequence of germline events. Undoubt-
edly, the stochastic process as defined by our transition probability could
be too rigid for the analysis of data arising from a cancer sample, where
microdeletions as well as a loss of an entire chromosomal arm might be
present. Further, noninteger copy numbers do make sense in such samples
due to the mix of normal and abnormal cells in the sample [i.e., mosaicism;
see Ting et al. (2006) for an example], while we assume the copy numbers
to be integers in our approach. While rare, noninteger copy numbers may
occur even in “normal” genomes (this can occur throughout the body or in
specific regions), and thus, may pose a problem for our algorithm. In general,
even if our method could be extended to allow for noninteger copy numbers
(at least the HMM for copy numbers, since the definition of “genotype” is
unclear in such a setting), the ability to pick up noninteger copy numbers
obviously depended on the quality of the data, the length of the non-normal
region, and the actual value of said copy number. For example, delineating
a small mosaic region in a sample with 95% normal cells and 5% of cells
with a hemizygous deletion would likely not be possible.
Our paper builds on a modular approach for analyzing SNP chip data,
extending the functionality of statistical algorithms that pre-process probe-
level data to produce SNP-level summaries of genotype and copy number.
Noticeably, these approaches have mostly been developed for the Affymetrix
platform (such as CRLMM for improved genotype estimates), but our ideas
are portable to other high throughput platforms such as Illumina. In partic-
ular, the vanilla HMM only relies on genotype (ĈN) and copy number (ĜT)
estimates without any confidence scores, which can be exported directly from
the Beadstudio software (http://www.illumina.com/). With one notice-
able (and very recent) exception suggested by Colella et al. (2007), previous
approaches using HMMs have considered genotype and copy number sepa-
rately, not simultaneously in a single unifying statistical model that allows
for the detection of copy number changes as well as copy neutral stretches
of homozygosity in the genome. In this sense, this manuscript is not the first
to propose such a unifying approach, albeit ours differs in several aspects
from the Bayesian HMM of Colella et al. (2007). In particular, the incorpo-
ration of uncertainty estimates can be critical, for example, in the detection
of microdeletions. The investigation of one particular sample as discussed in
this manuscript, however, does not allow for conclusive statements how the
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detected alterations are associated with the phenotype. In particular, it has
been well established that copy number variations and copy neutral stretches
of homozygous genotypes are prevalent in many phenotypically normal indi-
viduals. Identifying features that may be associated with a particular pheno-
type are better handled by statistical models for between-sample variation
in studies with phenotypically normal and diseased populations. Such mod-
els reside in the next tier of our modular approach to the analysis of SNP
chip data and are an extension of the ideas presented here.
In summary, we developed a HMM for SNP chips using the joint ob-
servation sequence of copy number (ĈN) and genotype (ĜT) estimates as
input. We demonstrated that a HMM model that uses both ĈN and ĜT can,
for example, distinguish copy-neutral LOH from deletion-induced LOH. We
also demonstrated how pre-processing algorithms that provide confidence
scores of SNP-level summaries can be integrated into the emission proba-
bilities of the HMM to control smoothing in a probabilistic framework, and
showed that this can lead to much improved results. Specifically, confidence
estimates allow smoothing to be more local or global depending on the un-
certainty of the pointwise estimates. We demonstrated how high confidence
scores helped in identifying a very small amplification otherwise missed (Fig-
ure 4, region E), while low confidence scores for ĈN and ĜT had the desir-
able effect of providing a more global smoothing (Figure 5). In particular, in
the experimental data example, this helped to reduce the number of regions
identified as LOH in the vanilla HMM, and eliminated the (presumably, spu-
rious) indication of a small deletion and a small amplification. We believe
that the ability to detect microdeletions and microamplifications could be of
utmost importance to explain the genetic basis of many diseases. Undoubt-
edly, this ability will greatly depend not only on the number of markers
investigated (such as the number of SNPs used on a particular platform)
and the quality of the data produced (i.e., the precision of the genotype and
copy number estimates), but also on how the uncertainty of the estimates
is utilized. In this sense, we hope that our method and software provides a
useful tool for the scientific community.
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